Literature DB >> 16006997

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.

Stefano Landi1, Federica Gemignani, Victor Moreno, Lydie Gioia-Patricola, Amélie Chabrier, Elisabeth Guino, Matilde Navarro, Javier de Oca, Gabriel Capellà, Federico Canzian.   

Abstract

OBJECTIVES: Sporadic colorectal cancer (CRC) is considered a multifactorial disease where multiple exposures interact with the individual genetic background resulting in risk modulation. We performed an association study aimed to investigate the role of single nucleotide polymorphisms (SNPs) within genes of phase I (CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, CYP2E1, CYP2C9, CYP2C19, CYP3A4, ADH2, EPHX1) and phase II of the xenobiotic metabolism (ALDH2, COMT, GSTA2, GSTA4, GSTM1, GSTM3, GSTP1, GSTT2, MTHFR, NAT1, NAT2, NQO1, MnSOD2, SULT1A1, TPMT).
METHODS: We genotyped 377 cases and 326 controls, by use of an oligonucleotide micro-array and the arrayed primer extension technique (APEX).
RESULTS: N-acetyl-transferase 1 'rapid' phenotype and CYP1A2 -164C>A carriers were associated with increased risk of CRC, confirming data reported in previous studies. Interestingly, homozygotes for allele 48G within CYP1B1, a variant with an increased activity towards several substrates including sex hormones, were at increased risk (OR=2.81, 95% CI 1.32-5.99). Moreover, CYP1A1 SNPs T461N and -1738A>C were associated with a reduced risk of cancer (OR=0.52; 95% CI 0.31-0.88 and OR=0.69, 95% CI 0.50-0.94 for carriers, respectively).
CONCLUSIONS: The present data suggest a role for CYP1B1 and CYP1A1 as new candidate genes in the etiology of CRC and confirm the carcinogenic role of aromatic amines metabolism for colorectum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16006997     DOI: 10.1097/01.fpc.0000165904.48994.3d

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  67 in total

1.  CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Guo-Wu Zhou; Jia Hu; Qiang Li
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

2.  MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies.

Authors:  Xuewen Sheng; Yanxi Zhang; Erjiang Zhao; Su Lu; Xiaoli Zheng; Hong Ge; Weiquan Lu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

3.  Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk.

Authors:  Monika Eichholzer; Sabine Rohrmann; Aline Barbir; Silke Hermann; Birgit Teucher; Rudolf Kaaks; Jakob Linseisen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

Review 4.  Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.

Authors:  Sang Wook Kang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials.

Authors:  Kathryn T Hall; Julie E Buring; Kenneth J Mukamal; M Vinayaga Moorthy; Peter M Wayne; Ted J Kaptchuk; Elisabeth M Battinelli; Paul M Ridker; Howard D Sesso; Stephanie J Weinstein; Demetrius Albanes; Nancy R Cook; Daniel I Chasman
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

6.  CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis.

Authors:  Jian-Qiang Jin; Yuan-Yuan Hu; Yu-Ming Niu; Gong-Li Yang; Yu-Yu Wu; Wei-Dong Leng; Ling-Yun Xia
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

7.  Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Wen-Xia Sun; Ying-Hua Chen; Zhi-Zhong Liu; Jian-Jun Xie; Wei Wang; Ya-Ping Du; Yu Chen; Xu-Liang Shen; Xiao-Feng He; Li-Xia Wu; Wu Wei; Lin Zhang
Journal:  Mol Genet Genomics       Date:  2014-12-04       Impact factor: 3.291

8.  Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.

Authors:  Jie-Ying Liu; Yu Yang; Zhi-Zhong Liu; Jian-Jun Xie; Ya-Ping Du; Wei Wang
Journal:  Mol Genet Genomics       Date:  2014-12-05       Impact factor: 3.291

9.  Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.

Authors:  Hae-Jeung Lee; Kana Wu; David G Cox; David Hunter; Susan E Hankinson; Walter C Willett; Rashmi Sinha; Eunyoung Cho
Journal:  Nutr Cancer       Date:  2013-10-07       Impact factor: 2.900

10.  The Association of the COMT V158M Polymorphism with Endometrial/Ovarian Cancer in HNPCC Families Adhering to the Amsterdam Criteria.

Authors:  Katie A Ashton; Cliff J Meldrum; Mary L McPhillips; Janina Suchy; Grzegorz Kurzawski; Jan Lubinski; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.